Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
Gints Kalnins, Laura Rudusa, Anna L Bula, Diana Zelencova‐Gopejenko, Olga Bobileva, Mihails Sisovs, Kaspars Tars, Aigars Jirgensons, Kristaps Jaudzems, Raitis Bobrovs · 2024
Read Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors by Gints Kalnins, Laura Rudusa, Anna L Bula, Diana Zelencova‐Gopejenko, Olga Bobileva, Mihails Sisovs, Kaspars Tars, Aigars Jirgensons, Kristaps Jaudzems, Raitis Bobrovs (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11648818.txt.
Description
Gints Kalnins and co-authors map how blockers jam a coronavirus copying enzyme in a 2024 study. The virus caps its RNA to look human and dodge immunity. Enzyme nsp16 adds the final methyl mark that completes the disguise. Stopping it could expose the virus.
Eleven crystal structures show substrate-like blockers bound to the enzyme pair. The blockers occupy the methyl donor site in varied poses. Some reach into the RNA site at the same time. Those dual-site binders inhibit the strongest. The structures hand drug designers a template: hit both pockets at once to shut the capping machine down.
Catalog record
| CREATOR | Gints Kalnins, Laura Rudusa, Anna L Bula, Diana Zelencova‐Gopejenko, Olga Bobileva, Mihails Sisovs, Kaspars Tars, Aigars Jirgensons, Kristaps Jaudzems, Raitis Bobrovs |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |